Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001140361-23-020316

Chief Legal and HR Officer sold 3,750 shares at $20.00 ($75,000)

  • Chief Legal and HR Officer acquired 3,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal and HR Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-21 Exercise or conversion : show line 1 in the form 10b5-1 +3,750 $8.04 $30,150 5,859 D
2023-04-21 Sale : show line 2 in the form 10b5-1 −3,750 $20.00 $75,000 2,109 D
Open-market sales · 3,750 sh · avg $20.00 · $75,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-21 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −3,750 52,500 D
Loading xslF345X04/form4.xml…